Hydrocortisone in Severe Community-Acquired Pneumonia | New …
Mar 21, 2023 · New perspectives on community-acquired pneumonia in 388 406 patients: results from a nationwide mandatory performance measurement programme in healthcare quality. …
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma | New …
Jun 4, 2023 · New York, NY 10065. A complete list of the investigators in the INDIGO trial is provided in the Supplementary Appendix , available at NEJM.org. Drs. Wen and Cloughesy …
Lumbar Puncture | New England Journal of Medicine
Sep 28, 2006 · Marton, KI, Gean, AD. The spinal tap: a new look at an old test. Ann Intern Med 1986;104:840-848
Pulmonary Arterial Hypertension | New England Journal of Medicine
Dec 15, 2021 · Other new mutations involve ATP13A3 (encoding ATPase 13A3); SOX17, which encodes SRY-box 17 and is a major risk factor for congenital heart disease–associated …
Diagnostic Criteria for Nonviable Pregnancy Early in the First ...
Oct 10, 2013 · Determining the viability of a pregnancy is a major challenge, especially with a pregnancy of unknown location. This review provides specific guidance, including stringent …
Clinical Cases | The New England Journal of Medicine
4 days ago · A 31-year-old woman was evaluated at 35 weeks 2 days’ gestation for a vaginal lesion. On examination, a nontender purple mass originating from the vaginal wall on the left …
A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer ...
Oct 22, 2015 · At 12 months, the rate of new nonmelanoma skin cancers was lower by 23% (95% confidence interval [CI], 4 to 38) in the nicotinamide group than in the placebo group (P=0.02).
Management of Insomnia | New England Journal of Medicine
Jul 17, 2024 · Insomnia is common and frequently occurs with other disorders. First-line cognitive behavioral therapy with or without medication can produce rapid, sustained alleviation of …
Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis …
Jan 18, 2023 · A total of 12,211 patients were randomly assigned to receive aspirin (6101 patients) or low-molecular-weight heparin (6110 patients). Patients had a mean (±SD) age of …
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH …
Feb 7, 2024 · From the University of Oxford, Oxford (S.A.H.), the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne …